10 9月 2021 by admin in UncategorizedComments Syros Announces Appointment of Deborah Dunsire, M.D., to Its Board of Directors
09 9月 2021 by admin in UncategorizedComments Syros Announces First Patient Dosed in SELECT-AML-1 Trial of Tamibarotene in Combination with Venetoclax and Azacitidine in Newly Diagnosed Unfit AML
08 9月 2021 by admin in UncategorizedComments Design Therapeutics Announces Positive Preclinical Data Highlighting Disease-Modifying Potential of its Novel DM1 GeneTACs as a Treatment for Myotonic Dystrophy Type-1
12 8月 2021 by admin in UncategorizedComments Tempest Reports Second Quarter 2021 Financial Results and Provides Corporate Highlights
12 8月 2021 by admin in UncategorizedComments Adicet Reports Second Quarter 2021 Financial Results and Provides Business Updates
09 8月 2021 by admin in UncategorizedComments Tempest Announces Appointment of Ronit Simantov, M.D. to its Board of Directors
09 8月 2021 by admin in UncategorizedComments Design Therapeutics Reports GeneTACTM Portfolio Progress and Second Quarter 2021 Results
05 8月 2021 by admin in UncategorizedComments Syros Reports Second Quarter 2021 Financial Results and Highlights Key Accomplishments and Upcoming Milestones
